Results 151 to 160 of about 7,988 (196)

Developing a 3D Model Culture of an EBV+/CD30+ B-Anaplastic Large Cell Lymphoma Cell Line to Assay Brentuximab Vedotin Treatment. [PDF]

Antibodies (Basel)
Giannoni P, Pietra G, Izzo O, Fugazza G, Benelli R, Poggi A, Krampera M, Utzeri C, Marchese M, Musso M, Visconti P, de Totero D.   +11 more
europepmc   +1 more source

Engineered retargeting to overcome systemic delivery challenges in oncolytic adenoviral therapy. [PDF]

Mol Ther Oncol
Leparc L, Wakimoto H.
europepmc   +1 more source

Nanobody Therapeutics in Alzheimer's Disease: From Molecular Mechanisms to Translational Approaches. [PDF]

Antibodies (Basel)
Godugu D, Gattu K, Suri P, Daartey AB, Jadhav K, Rojekar S.   +5 more
europepmc   +1 more source

Immunotoxins

Biomedicine & Pharmacotherapy, 1989
openaire   +1 more source

Microalgae as novel drug-delivery system for biomedical field. [PDF]

Drug Deliv
Dai Y, Guo D, Li A, Chen W, Yang Y, Li S, Yang L, Feng S.   +7 more
europepmc   +1 more source

Cadherin 17 Nanobody-Mediated Near-Infrared-II Fluorescence Imaging-Guided Surgery and Immunotoxin Delivery for Colorectal Cancer. [PDF]

Biomater Res
Ding Y, Zhou R, Shi G, Jiang Y, Li Z, Xu X, Ma J, Huang J, Fu C, Zhou H, Wang H, Li J, Dong Z, Yu Q, Jiang K, An Y, Liu Y, Li Y, Yu L, Li Z, Zhang X, Wang J.   +21 more
europepmc   +1 more source

Bacterial exotoxins in medicine: potential value and perspectives. [PDF]

Int J Med Sci
Xiao Y, Yan Z, Ren F, Tan Y.
europepmc   +1 more source

Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy. [PDF]

Ther Adv Med Oncol
Izzo D, Ascione L, Guidi L, Marsicano RM, Koukoutzeli C, Trapani D, Curigliano G.   +6 more
europepmc   +1 more source

CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge. [PDF]

Oncol Res
Guo X, Fu Y, Baran N, Ma W.
europepmc   +1 more source

A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy. [PDF]

Acta Pharm Sin B
Xi X, Wang Y, An G, Feng S, Zhu Q, Wu Z, Chen J, Zuo Z, Wang Q, Wang MW, Gu Y.   +10 more
europepmc   +1 more source